Trade and Transaction Reporting: What good can come of it? Free Webinar | 30th June

+0

Trade reporting is an on-going obligation for firms who use OTC products. The number of jurisdictions requiring reporting keeps increasing, and the formats for data keep changing. In this webinar we want to discuss the positive benefits of compliance with OTC (and other) trade reporting, and how that brings opportunities to use the data to improve the internal environment at your firm. We all know that the accurate capture of trades is vital to every aspect of the operation of an OTC user. How does trade reporting improve and enhance record keeping, and derived functions like risk management, credit risk, collateral and regulatory capital calculations? At a basic level why does trade reporting change the way firms approach their controls around data and reconciliations?

Join us for a Free Webinar on Trade and Transaction Reporting: What good can come of it?

30th June 2016: 3pm BST (10am ET)

There is no end of research extoling the grim realities or lamenting the high costs and negative impacts of Trade and Transaction Reporting, unfortunately, it’s not going away. We thought it was time to explore the positive perspective. In this live event we have asked 4 firms with varying stakes in the Trade and Transaction Reporting domain to discuss the perceived, achieved and potential positives to be gained from this unavoidable obligation.

  • Having been forced to combine and align multiple sources of transaction data, are there internal benefits that have accrued or may accrue?
  • What data quality controls have been built and how have they benefited the market as a whole?
  • Has the need for matching at the trade repository improved the quality or integrity of intra-firm processes? Confirmations, settlements etc?
  • Has delegated reporting improved clients access to data and understanding of the operational flows?
  • What have we learned from the public data?

Our speaking roster includes:

Brian Lynch

CEO: Riskfocus

Brian Lynch is the Chief Executive Officer of Risk Focus, responsible for defining and executing company strategy. Prior to joining the company in 2011, Brian spent 14 years at UBS, most recently as Chief Operating Officer for Delta One trading, a role in which he successfully brought several new business lines and products to market. He also has many years experience at the bank in fixed income, credit default swaps and prime brokerage. Brian received his Bachelor of Science in Construction Management from the University of Witwatersrand.

Steve French

Director of Product Marketing: Traiana

Steve French is director of product strategy at Traiana, a provider of post-trade processing and risk-management services. 

Chris Barnes

Subject Matter Expert: ClarusFT

Chris has over 12 years experience trading OTC Derivatives markets. He cut his teeth trading Cross Currency Swaps at HSBC in London between 2002 and 2010, before helping to launch Rates Trading at State Street in London (2010-2012). Having relocated to Switzerland, he was most recently Director of Product Development at Gottex. Chris holds an MA from the University of Cambridge in Natural Sciences, where his dissertation on artificial intelligence was published in 2001.

Gavin Dixon

Independent Consultant, ex-COO Credit Trading at BNP Paribas

Gavin is a Senior Level Executive, is ACA qualified with a BCommerce (Accounting) degree, and has extensive experience working in Global Capital Markets which he gained while working for leading financial institutions, such as BNP Paribas and Deutsche Bank. His key areas of expertise include COO/Business Management, managing Capital Markets Middle Office & Operations teams, and building an OTC Clearing offering from inception.

Bill Hodgson

Owner The OTC Space, Moderator

Bill's career has included a wide variety of businesses including cash registers, children’s games, RADAR, oil drilling and for the past 20 years the capital markets, especially OTC derivatives. In the capital markets he initially worked on developing software to process OTC derivatives at Merrill Lynch, in the days when paper trade tickets were still the norm. Subsequently he has worked with major banks to improve their OTC processing capabilities, including with Barclays Capital as Head of OTC (ISDA) Projects, LCH.Clearnet as Head of Product Development for the SwapClear service and at DTCC to design, build and deploy the Trade Information Warehouse for Credit Default Swaps. He originally qualified at Greenwich University in Computing, and is a contributor to three books on OTC products and capital markets and is the owner of The OTC Space Ltd.

This webinar will be hosted via 'GoToWebinar'. To join the webinar, submit the form below and join a test webinar to check that your technology is compatible (most are).The webinar will allow you to ask questions to the panel in real time, and will be published as a video shortly after.

Registrations for this webinar are now closed. The webinar was recorded live, and will soon be available on The OTC Space for those who weren't able to join it live.

Share